Article
Btk dosage determines sensitivity to B cell antigen receptor cross-linking.
Proceedings of the National Academy of Sciences of the United States of America - 25 Nov 1997
Satterthwaite A B, Cheroutre H, Khan W N, Sideras P, Witte O N
Abstract excerpt
Mutations in Btk result in the B cell immunodeficiencies X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Btk is a critical component of signaling pathways regulating B cell development and function. We used a genetic approach to determine whether Btk is also limiting for these processes. One allele of a murine Btk transgene expressed a dosage of Btk (25% of endogenous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
